A Canadian multi-centre, open-label long-term study of Pegvisomant treatment in refractory acromegaly.

Autor: Ezzat, Shereen1 sezzat@mtsinai.on.ca, Gaspo, Rania2, Serri, Omar3, Ur, Ehud4, Chik, Constance L.5
Zdroj: Clinical & Investigative Medicine. Dec2009, Vol. 32 Issue 6, pE265-E277. 13p. 3 Charts, 2 Graphs.
Databáze: Academic Search Ultimate